Member of Lyonbiopole
Recognized for its expertise in the development and manufacture of medical devices and delivery systems, BIOCORP has today acquired a leading position in the connected medical device market thanks to Mallya. This intelligent sensor for insulin injection pens allows reliable monitoring of injected doses and thus offers better compliance in the treatment of diabetics. Available for sale from 2020, Mallya spearheads BIOCORP's product portfolio of innovative connected solutions.
Strategic application domain: Medical Technologies
Application market: Metabolic Disorders - Endocrinology, Ophthalmology, Pneumology - Respiratory Diseases
Type of activity: CRO - Tools - R&D platform, E-Health, Medical device
Technologies: Drug delivery device & Technologies
Created on jan. 1st, 2004 - 74 employees
Address
PT Lavaur La Béchade 63500 ISSOIRE
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.